SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $973,000 | -38.4% | 19,321 | -26.8% | 0.05% | -44.2% |
| Q2 2018 | $1,579,000 | -52.1% | 26,389 | -63.3% | 0.10% | -60.1% |
| Q1 2018 | $3,297,000 | -43.5% | 71,989 | -50.8% | 0.24% | -48.1% |
| Q4 2017 | $5,834,000 | +22.8% | 146,396 | +23.2% | 0.46% | +15.9% |
| Q3 2017 | $4,751,000 | -7.3% | 118,782 | -0.1% | 0.40% | -16.1% |
| Q2 2017 | $5,125,000 | -14.2% | 118,907 | -37.7% | 0.47% | -21.3% |
| Q1 2017 | $5,976,000 | -66.7% | 190,938 | -73.2% | 0.60% | -2.8% |
| Q4 2016 | $17,968,000 | -10.0% | 711,599 | -11.8% | 0.62% | -5.7% |
| Q3 2016 | $19,958,000 | +13.8% | 807,049 | -6.3% | 0.65% | +2.3% |
| Q2 2016 | $17,538,000 | +195.0% | 860,969 | +120.9% | 0.64% | +195.8% |
| Q1 2016 | $5,945,000 | – | 389,840 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |